Daniel Diolaiti, Ph.D., currently serves as the Director of Scientific Regulatory Strategy at Pfizer, where they are responsible for regulatory submissions related to oncology pharmacology. Previously, Daniel held various roles at leading research institutions, including Senior Research Scientist at Memorial Sloan Kettering Cancer Center and Principal Scientist at Seagen, focusing on cancer drug development and therapeutic strategies. Daniel earned a Ph.D. in Cellular and Molecular Biology from the University of Bologna and contributed significantly to numerous scientific advancements throughout their career.
This person is not in any teams
This person is not in any offices